Cancer funding

    Fort Washington-based National Comprehensive Cancer Network has been awarded a $2.1 million grant.

    The grant from Pfizer will help develop a program to study axitinib in tumors, the Business Journal reports. Axitinib could be linked to the growth and metastatic progression of tumors.

     

    Want a digest of WHYY’s programs, events & stories? Sign up for our weekly newsletter.

    It will take 126,000 members this year for great news and programs to thrive. Help us get to 100% of the goal.